An FDA advisory panel recommended the agency allow a birth control pill to be available over the counter in the U.S. for the first time, saying the benefits outweigh the risks.
An FDA advisory panel on Wednesday unanimously recommended the agency allow a birth control pill to be available over the counter in the U.S.The panel came to the decision after a two-day public meeting mostly centered on if people could safely and effectively take the birth control drug Opill without professional supervision. Experts on the panel said they were confident they could, and the benefits of making the pill more widely available far outweigh any risks.
"The evidence demonstrates that the benefits clearly exceed the risks," Curtis said. "The benefits of moving Opill over the counter include increased access to contraception…, reduction in unintended pregnancy and associated risks, and improved reproductive autonomy and improved equitable access to contraception."
The panel largely set aside initial concerns Wednesday when given the opportunity to ask questions about Perrigo's research. Medical organizations, including the American Medical Association, the American College of Obstetricians and Gynecologists support selling the birth control pill over the counter.
"Decades of coalition-driven advocacy and research efforts that have centered the voices of those most impacted by barriers to contraception caused by systemic inequities have made this possible," Nichols said in a Wednesday statement. "It is past time for an over-the- counter birth control pill, which has the potential to advance reproductive justice and expand health equity.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
FDA panel backs over-the-counter birth control pillFederal health advisers are recommending that a decades-old birth control pill be sold without a prescription
Lire la suite »
FDA panel backs over-the-counter birth control pillFederal health advisers are recommending that a decades-old birth control pill be sold without a prescription. The positive vote on Wednesday by a Food and Drug Administration panel paves the way for what could be the first birth control pill available over the counter. The recommendation is not binding and the FDA is expected to make its decision on the drug this summer. Currently all contraceptive pills in the U.S. require a prescription. Dozens of medical and advocacy groups support making the pill available without a prescription to increase birth control options for women.
Lire la suite »
FDA Panel Backs Over-The-Counter Birth Control PillFederal health advisers are recommending that a decades-old birth control pill be sold without a prescription.
Lire la suite »
FDA panel backs over-the-counter birth control pillU.S. Food and Drug Administration advisers endorsed the first over-the-counter sales of a birth control pill, with a final decision expected this summer.
Lire la suite »
FDA panel backs over-the-counter birth control pill, teeing up approvalBREAKING: An FDA panel voted to back the sale of an over-the-counter birth control pill, clearing the way for approval.
Lire la suite »
FDA panel backs over-the-counter birth control pillIf the agency follows the nonbinding recommendation, Perrigo’s drug, Opill, would become the first contraceptive pill to be moved out from behind the pharmacy counter onto store shelves.
Lire la suite »